Sponsored by
We (The Musella Foundation with the help of our fantastic donors!) helped fund this research project. They found that just adding a drug that inhibits the main way the Glioblastoma cells move did not really help much. In fact, they found that the cells easily and quickly used a different mechanism to move. Combining inhibitors of both pathways did help. A lot, but not completely - a 3rd drug might be needed to target the resistance pathway. They did find a biomarker in the blood that may predict recurrence of Glioblastoma. More work needs to be done to validate the biomarker and to completely eliminate invasion! Good work!